Pharm-Olam Selected as a CRO for Department of Defense Support to Operation Warp Speed Vaccine Trials, Partnering with Geneva Foundation

Pharm-Olam selected by U.S. Department of Defense to support Phase III clinical trials of Operation Warp Speed COVID-19 vaccine candidates.